[ad_1] Investors have done their best to capitalize on cannabis by looking closely at marijuana stocks. Aurora Cannabis (NASDAQOTH:ACBFF) (TSX:ACB) has sought to make it even easier for U.S. investors to buy …
Read More »
[ad_1] On Thursday, October 18, 2018, Tobacco International Philip Morris International (PM) announced its third-quarter 2018 earnings results. Overall, these results beat the expectations of analysts on both the top- and bottom-lines. …
Read More »
[ad_1] Co-produced with the authors Long Player and Philip Mause for High Dividend Opportunities. Intermediate partners of the Summit (SMLP) recently traded at a price of $ 14.77 and pays an annual …
Read More »
[ad_1] It's time to have a serious discussion about weeds. Investors achieved impressive returns with pot stocks, including Canopy Growth (CGC), Tilray (TLRY) and Cronos Group (CRON). But the story of growth …
Read More »
[ad_1] The Wall Street Journal reported Tuesday that the Securities and Exchange Commission said on Tuesday that the country's major stock exchanges do not sufficiently warrant the increase in fees that they …
Read More »
[ad_1] Alibaba Holding Group (BABA) has taken a hit, and everyone knows it. The stock is almost 33% from its 52-week high. In this article, I share my reasoning for not increasing …
Read More »
[ad_1] Michael Nagle | Bloomberg | Getty Images Frank Calderoni, President and CEO of Anaplan Inc., at the center, rings the opening bell of the company's initial public offering (IPO) on the …
Read More »
[ad_1] Share on Facebook Share on Twitter Share on linkedin <div _ngcontent-c15 = "" innerhtml = " Photographer: Jason Franson / Bloomberg Aurora Cannabis announced today its application for listing on the …
Read More »
[ad_1] Medical marijuana plants at Aurora Cannabis's operation near Cremona, Alta. Jeff McIntosh / The Globe and Mail Part of cannabis and investing Expand stories Available now: Cannabis Professional, the authoritative e-mail …
Read More »
[ad_1] Results from a Phase 3 clinical trial, UNIFI, on Janssen Pharmaceuticals (NYSE: JNJ) STELARA (ustekinumab) from Johnson & Johnson (NYSE: JNJ) in adult patients with moderate to severe ulcerative colitis who …
Read More »